For Sarepta, the hits keep coming, with several downgrades in the past week after it was forced to temporarily take its ...

"Time is ticking," said Lindsay Marjoram, the director of research for the Barth Syndrome Foundation, told KETV. "If the ...

PepsiCo and Dr Pepper have sold versions of their flagship sodas sweetened with cane sugar since 2009. Coca-Cola has sold ...

Elevated levels of lead and cadmium can cause significant health problems, particularly among infants and children.

U.S. Food and Drug Administration employees told CNN that Elsa — the AI model that’s supposed to help speed up approvals of pharmaceuticals and medical devices — isn’t working great. Instead, it cites ...

In 2022, President Joe Biden signed The Modernization of Cosmetic Regulations Act, or MoCRA, into law, which expanded FDA ...

The affected bars were distributed in 23 states: Florida, California, Pennsylvania, Ohio, Georgia, New York, New Jersey, Texas, Virginia, Arizona, Alabama, Wisconsin, Illinois, Missouri, Massachusetts ...

The Food and Drug Administration won’t sign off on Sarepta Therapeutics Inc. bringing its controversial gene therapy back to ...

BioPoly, an orthopedic startup based in Fort Wayne, is approaching the start of an FDA-approved clinical trial of a knee ...

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center for Drug Evaluation and Research (CDER).

The FDA is taking steps to ban current prescriptions.